Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-17 of 17 for your search:
Drug:  brentuximab vedotin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-005, NCT01100502

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-016, NCT01874054

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG035-0003, 2008-006034-10, NCT00848926

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG035-0004, 2008-006035-12, NCT00866047

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 12 to 120
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-006, 2010-019932-11, NCT00947856

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 6 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-012, NCT01421667

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 6 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-013, NCT01461538

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 12 to 72
Sponsor: Other
Protocol IDs: 11-142, NCT01508312

9.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-462, NCT01534078

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: Targeted BEACOPP, NCT01569204

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SG035-0001, NCT00430846

12.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-007, NCT01026233

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-008, NCT01026415

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-009, NCT01060904

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-011, 2010-022839-11, NCT01309789

16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-01273, 13-044, 9467, U01CA069856, P30CA008748, NCT01902160

17.

Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: SGN35-010, NCT01196208
New Search